Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment (Q34631614)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment |
scientific article |
Statements
1 reference
Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment (English)
1 reference
Mark F Bear
1 reference
Brian P Schoenfeld
1 reference
Catherine H Choi
1 reference
Aaron J Bell
1 reference
Paul Hinchey
1 reference
Maria Kollaros
1 reference
Michael J Gertner
1 reference
Newton H Woo
1 reference
Michael R Tranfaglia
1 reference
R Suzanne Zukin
1 reference
Thomas V McDonald
1 reference
Thomas A Jongens
1 reference
Sean M J McBride
1 reference
12 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference